Overview

A Study of APR-246 in Oesophageal Cancer

Status:
Suspended

Trial end date:
2019-10-07

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether APR-246, 5-FU and cisplatin are safe and effective in the treatment of platinum resistant oesophageal cancer.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Peter MacCallum Cancer Centre, Australia